These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ocular pharmacokinetics of carnosine 5% eye drops following topical application in rabbit.
    Author: Tianyang Z, Ling Z, Liya W, Junjie Z.
    Journal: J Ocul Pharmacol Ther; 2011 Feb; 27(1):93-7. PubMed ID: 20085487.
    Abstract:
    PURPOSE: To evaluated the ocular pharmacokinetics of carnosine (CAR, a biologically active dipeptide which occurs naturally throughout the human body) 5% eye drops following topical application. METHODS: CAR 5% eye drops were topically applied repeatedly (50 μL × 4) at an interval of 5 min. Aqueous humor and lens were collected after 5, 15, 30, 45, 60, 90, 120, 150, and 180 min. CAR concentration was determined by high performance liquid chromatography-tandem quadrupole mass spectrometer (HPLC-MS/MS). RESULTS: CAR concentration in treated eyes was significantly higher than control eyes. Peak concentration (C(max)) of carnosine in treated aqueous humor occurred 60 min following topical administration, with the administrated concentration (total-endogenous concentration) of 40.9 ± 18.9 μg/mL. The area under the concentration-time curve between 0 and 180 min (AUC(0-180)) was 3,276.8 (μg/mL) × min. CAR concentration in treated lens rises to effective level rapidly and changes slightly with time after topical administration. The administrated concentration of car in lens at the last time point (180 min, 1.92 ± 1.65 μg/mL) was not significantly different with the highest value (15 min, 2.11 ± 1.83 μg/mL). CONCLUSIONS: CAR 5% eye drops were likely to be absorbed into aqueous humor efficiently and accumulated in lens. More attention should be put onto enhancing the penetration of CAR into lens capsule.
    [Abstract] [Full Text] [Related] [New Search]